Comparative randomised trial of high and conventional doses of praziquantel in the treatment of schistosomiasis mansoni

Memorias do Instituto Oswaldo Cruz

Volumn 105, Issue 4, 2010, Pages 445-448

  de Queiroz, Leonardo C ^a   Drummond, Sandra C ^b   de Matos, Maria Laura M ^a   Paiva, Mariana Bs ^a   Batista, Thaís S ^a   Kansaon, Ahraby Z M ^a   Antunes, Carlos Maurício de F ^a   Lambertucci, José Roberto ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b Secretaria de Estado de Saúde Governo do Estado de Minas Gerais Belo Horizonte   (Brazil)

Author keywords

Adverse reactions; Praziquantel; Schistosomiasis; Schistosomiasis mansoni; Therapeutic efficacy; Treatment

Indexed keywords

EID: 77955485234     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/s0074-02762010000400015     Document Type: Article

References (22)

1. Amaral RS, Tauil PL, Lima DD, Engels D 2006. An analysis of the impact of the Schistosomiasis Control Programme in Brazil. Mem Inst Oswaldo Cruz 101 (Suppl. 1): 79-85.
2. Botros S, Sayed H, Amer N, El-Ghannam M, Bennett JL, Day TA 2005. Current status of sensitivity to praziquantel in a focus of potential drug resistance in Egypt. Int J Parasitol 35: 787-791.
3. Coutinho AD, Domingues AL, Florêncio JN, Almeida ST 1984. Treatment of hepatosplenic schistosomiasis mansoni with prazi-quantel. Rev Inst Med Trop Sao Paulo 26: 38-50.
4. da Cunha AS, Cançado JR, de Rezende GL 1987. Therapeutical evaluation of different dose regimens of praziquantel in schistoso-miasis mansoni, based on the quantitative oogram technique. Rev Inst Med Trop Sao Paulo 29: 295-304.
5. Doenhoff MJ, Kusel JR, Coles GC, Cioli D 2002. Resistance of Schis-tosoma mansoni to praziquantel: is there a problem? Trans R Soc Trop Med Hyg 96: 465-469.
6. Drummond SC, Silva LCS, Amaral RS, Sousa-Pereira SR, Antunes CM, Lambertucci JR 2006. Morbidity of schistosomiasis man-soni in the state of Minas Gerais, Brazil. Mem Inst Oswaldo Cruz 101 (Suppl.1): 37-44.
7. Kabatereine NB, Kemijumbi J, Ouma JH, Sturrock RF, Butterworth AE, Madsen H, Ornbjerg N, Dunne DW, Vennnervald BJ, 2003. Efficacy and side effects of praziquantel treatment in a highly endemic Schistosoma mansoni focus at Lake Albert, Uganda. Trans R Soc Trop Med Hyg 97: 599-603.
8. Katz N, Rocha RS 1982. Double-blind clinical trial comparing prazi-quantel with oxamniquine in schistosomiasis mansoni. Rev Inst Med Trop Sao Paulo 24: 310-314.
9. Katz N, Rocha RS, Chaves A 1979. Preliminary trials with praziquan-tel in human infections due to Schistosoma mansoni. Bull World Health Organ 57: 781-785.
10. Lambertucci JR 1993. Schistosoma mansoni: pathological and clinical aspects. In P Jordan, G Webbe, RF Sturrock (eds.), Human schistosomiasis, Cab International, Wallingford, p. 195-225.
11. Lambertucci JR, Cota GF, Pinto-Silva RA, Serufo JC, Gerspacher-Lara R, Drummond SC, Antunes CM, Nobre V, Rayes A 2001. Hepatosplenic schistosomiasis in field-based studies: a combined clinical and sonographic definition. Mem Inst Oswaldo Cruz 96 (Suppl.): 147-150.
12. Lambertucci JR, dos Santos Silva LC, Andrade LM, de Queiroz LC, Carvalho VT, Voieta I, Antunes CM 2008. Imaging techniques in the evaluation of morbidity in schistosomiasis mansoni. Acta Trop 108: 209-217.
13. Lambertucci JR, Greco DB, Pedroso ER, da Costa Rocha MO, Sala-zar HM, de Lima DP 1982. A double blind trial with oxamniquine in chronic schistosomiasis mansoni. Trans R Soc Trop Med Hyg 76: 751-755.
14. Lambertucci JR, Rocha RS, Carvalho OS, Katz N 1987. A esquis-tossomose mansoni em Minas Gerais. Rev Soc Bras Med Trop 20: 47-52.
15. Lambertucci JR, Serufo JC, Gerspacher-Lara R, Rayes AA, Teixeira R, Nobre V, Antunes CM. 2000. Schistosoma mansoni: assessment of morbidity before and after control. Acta Trop 77: 101-109.
16. Leopold G, Ungethüm W, Groll E, Diekmann HW, Nowak H, Wegner DH 1978. Clinical pharmacology in normal volunteers of prazi-quantel, a new drug against schistosomes and cestodes. An example of a complex study covering both tolerance and pharma-cokinetics. Eur J Clin Pharmacol 14: 281-291.
17. Prata A, Castro N, Silva AE, Paiva M, Macêdo V, Junqueira LF Jr 1982. Praziquantel in the treatment of schistosomiasis mansoni. Rev Inst Med Trop Sao Paulo 24: 95-103.
18. Rabello AL, Rocha RS, de Oliveira J P, Katz N, Lambertucci JR 1992. Stool examination and rectal biopsy in the diagnosis and evaluation of therapy of schistosomiasis mansoni. Rev Inst Med Trop Sao Paulo 34: 601-608.
19. Raso G, N'Goran EK, Toty A, Luginbühl A, Adjoua CA, Tian-Bi NT, Bogoch II, Vounatsou P, Tanner M, Utzinger J 2004. Efficacy and side effects of praziquantel against Schistosoma mansoni in a community of western Côte d'Ivoire. Trans R Soc Trop Med Hyg 98: 18-27.
20. Utzinger J, Keiser J, Shuhua X, Tanner M, Singer BH 2003. Combination chemotherapy of schistosomiasis in laboratory studies and clinical trials. Antimicrob Agents Chemother 47: 1487-1495.
21. WHO - World Health Organization 1985. The control of schistosomi-asis. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser 728: 1-113.
22. Xiao SH, Catto BA 1989. In vitro and in vivo studies of the effect of artemether on Schistosoma mansoni. Antimicrob Agents Chemother 33: 1557-1562.